Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (7887)	10/23/2001 7:36:16 PM
From: Mark Bartlett	Read Replies (2) \| Respond to of 14101

Hi Cal, I am not as familiar with Virulizin as I am with WF10. It certainly sounds interesting and appears to have some of the same effects as WF10. I would be interested to know what effect, if any, it has on the various pro-inflammatroy cytokines and chemokines. I quickly looked at Lorus about 1.5 years ago but because they were still quite far behind in their regulatory testing, I just made a mental note to revisit. Looks like it may be time to revisist. That being said, we are likely looking at something that is at least 4 years to market. Take care, Mark